Compare Ascendis Pharma A/S (ASND) vs First Trust NASDAQ Cybersecurity ETF (CIBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs First Trust NASDAQ Cybersecurity ETF — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while First Trust NASDAQ Cybersecurity ETF trades at $99.82. The key difference: First Trust NASDAQ Cybersecurity ETF is trading nearer its 52-week high, Ascendis Pharma A/S nearer its low. Which is the better fit depends on your goals.
| ASND | CIBR | |
|---|---|---|
Market Cap | $16.67B | — |
Sector | Health | — |
52-Week High | $277.18 | $100.60 |
52-Week Low | $189.74 | $60.74 |
Enterprise Value | $17.04B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About First Trust NASDAQ Cybersecurity ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →
